FAM32DP

Across TCGA pan-cancer cohorts, FAM32DP RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated FAM32DP data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher FAM32DP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM32DP expression acts as an unfavorable survival marker, although some lineages such as GBM and ESCA show a favorable association.

ACC, MESO, and LIHC are the cancer types where FAM32DP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	III,IV	0.345	0.766	<.001	69	view →
MESO	OS	Tertile	All	0.130	0.557	.019	54	view →
LIHC	DFS	Tertile	All	0.081	0.527	.012	54	view →
TGCT	DFS	Tertile	All	0.360	0.811	.002	36	view →
BLCA	DFS	Tertile	III,IV	0.176	0.574	.011	27	view →
STAD	DFS	Tertile	All	0.405	0.724	.014	18	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
GBM	DFS	Tertile	All	0.540	0.190	.018	12	view →
ESCA	DFS	Tertile	III,IV	1.000	0.280	.042	12	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

FAM32DP–ACC (OS)

Open the ACC breakdown →